At Archimica, we're thrilled to explore the transformative potential of Sucrose Octasulfate Potassium Salt (KSOS) in revolutionizing pharmaceutical applications. From enhancing the stability of high-value treatments to improving liposome-based drug delivery systems, ...
Archimica is excited to be a part of DCAT Week 2025, where we'll be showcasing our latest breakthroughs and innovations in pharmaceutical manufacturing. Let's connect and discuss how we can ...
We are happy to announce that Archimica is now CEP (Certification of Suitability) certified by the EDQM (European Directorate for the Quality of Medicines & HealthCare) for our API product, ...
We are happy to announce that Archimica S.p.A , group member of PIHS company, will be exhibiting at CPhI Worldwide 2023 in Barcelona. PI Health Sciences booth #3E29 will be ...
We are happy to announce that Archimica S.p.A will be exhibiting at CPhI Worldwide 2022 in Frankfurt. Our Team will attend the event from the 1st to 3rd of November ...
September 5, 2022 Archimica continues Expansion - Announces completion of its 2 Mio. Euro Investment Upgrade of its Multi-Purpose Manufacturing Capacity Archimica has started the operation of its state-of-the art ...
We are happy to announce that Archimica S.p.A will be exhibiting at CPhI Worldwide 2021 in Milano. Our Team will attend the event from the 9th - 11th of November at Fiera ...
July 22, 2021 Archimica announces completion of its 1,2 Mio. Euro Investment Expansion of its Multi-Purpose Manufacturing Capacity on CPHI North America Archimica has started the operation of its expanded ...
25 May 2021 Archimica invests 1,3 Mio. Euro in Expansion of Process Development Capacity Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. A ...